Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)
Authors not listed
University of California, San Diego · 2011
Abstract
To determine if patients treated early after diagnosis of wet age-related macular degeneration can return/maintain to their baseline pre-disease BCVA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2011). Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS). <em>University of California, San Diego</em>. https://clinicaltrials.gov/study/NCT01402544
Vancouver
Anonymous. Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS). University of California, San Diego. 2011.
BibTeX
@misc{anon2011Clinic,
title = {Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)},
author = {Anonymous},
journal = {University of California, San Diego},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Control Delivery Systems 2001
Open access · US-GOV
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Advanced Drug Delivery Reviews 2005
Citation only
Wet age-related macular degeneration
JAMA ophthalmology 2026
Citation only
Reported Metformin Use and Age-Related Macular Degeneration in Patients With Diabetes.
Ophthalmology 2007
Citation only
Cigarette Smoking and Age-Related Macular Degeneration in the EUREYE Study
Drugs & Aging 2002
Citation only